Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial-Reference-Cited by-同舟云学术

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial

Published:2017-03-31 Issue:7 Volume:56 Page:524-534
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Stevens-Kroef Marian J.¹^ORCID,Olde Weghuis Daniel¹,ElIdrissi-Zaynoun Najat¹,van der Reijden Bert²,Cremers Eline M. P.³,Alhan Canan³,Westers Theresia M.³,Visser-Wisselaar Heleen A.⁴,Chitu Dana A.⁴,Cunha Sonia M.⁴,Vellenga Edo⁵,Klein Saskia K.⁶,Wijermans Pierre⁷,de Greef Georgine E.⁸,Schaafsma M. Ron⁹,Muus Petra¹⁰,Ossenkoppele Gert J.³,van de Loosdrecht Arjan A.³,Jansen Joop H.²

Affiliation:

1. Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands

2. Department of Laboratory Medicine; Radboud University Medical Center; Nijmegen The Netherlands

3. Department of Hematology; VU University Medical Center, Cancer Center Amsterdam; Amsterdam The Netherlands

4. Department of Hematology; Erasmus MC Cancer Institute, HOVON Data Center, Erasmus University Medical Center-Daniel den Hoed; Rotterdam The Netherlands

5. Department of Experimental Hematology; University Medical Center Groningen; Groningen The Netherlands

6. Department of Internal Medicine; Meander Medisch Centrum; Amersfoort The Netherlands

7. Department of Internal Medicine; Haga Ziekenhuis; The Hague The Netherlands

8. Department of Hematology; Erasmus University Medical Center-Daniel den Hoed; Rotterdam The Netherlands

9. Department of Internal Medicine; Medisch Centrum Twente; Enschede The Netherlands

10. Department of Hematology; Radboud University Medical Center; Nijmegen The Netherlands

Funder

European FP7

Radboud Oncology Fund

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference43 articles.

1. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet;Malcovati;Blood.,2013

2. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients;Haase;Blood.,2007

3. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge;Schanz;J Clin Oncol.,2012

4. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood.,2016

5. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood.,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refined cytogenetic IPSS‐R evaluation by the use of SNP array in a cohort of 290 MDS patients;Genes, Chromosomes and Cancer;2023-07-14

2. Shallow whole‐genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics;Genes, Chromosomes and Cancer;2023-06-09

3. British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes;British Journal of Haematology;2021-06-16

4. Clinical implications of copy number alteration detection using panel-based next-generation sequencing data in myelodysplastic syndrome;Leukemia Research;2021-04

5. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies;Current Hematologic Malignancy Reports;2020-05-07